Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- ISSCR Unveils Roadmap for Advancing Pluripotent Stem Cell-Derived Therapies
- New gene therapy slows progression of Huntington’s disease by 75%
- Adult Stem Cells Improve Vision in Patients With Macular Degeneration
- Lab-grown kidneys show real function in new stem cell study
- Common Nutrient Found To Supercharge Immune Cells Against Cancer
- Junk DNA” Found to Sense Its Environment, May Hold the Key to Disease Treatment